Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
ClinicalTrials.gov Identifier: NCT04292730.
Publications
2 shownSARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
In this interim analysis of a phase 2 trial, one of three doses of neutralizing antibody LY-CoV555 appeared to accelerate the natural decline in viral load over time, whereas th...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,662
- Institution
- Cook County Health and Hospitals System
External Links
Identifiers
- ORCID
- 0000-0002-4699-5467
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.